首页> 外文OA文献 >Guar Gum, Xanthan Gum, and HPMC Can Define Release Mechanisms and Sustain Release of Propranolol Hydrochloride
【2h】

Guar Gum, Xanthan Gum, and HPMC Can Define Release Mechanisms and Sustain Release of Propranolol Hydrochloride

机译:瓜尔胶,黄原胶和HPMC可以确定盐酸普萘洛尔的释放机理和持续释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objectives were to characterize propranolol hydrochloride-loaded matrix tablets using guar gum, xanthan gum, and hydroxypropylmethylcellulose (HPMC) as rate-retarding polymers. Tablets were prepared by wet granulation using these polymers alone and in combination, and physical properties of the granules and tablets were studied. Drug release was evaluated in simulated gastric and intestinal media. Rugged tablets with appropriate physical properties were obtained. Empirical and semi-empirical models were fit to release data to elucidate release mechanisms. Guar gum alone was unable to control drug release until a 1:3 drug/gum ratio, where the release pattern matched a Higuchi profile. Matrix tablets incorporating HPMC provided near zero-order release over 12 h and erosion was a contributing mechanism. Combinations of HPMC with guar or xanthan gum resulted in a Higuchi release profile, revealing the dominance of the high viscosity gel formed by HPMC. As the single rate-retarding polymer, xanthan gum retarded release over 24 h and the Higuchi model best fit the data. When mixed with guar gum, at 10% or 20% xanthan levels, xanthan gum was unable to control release. However, tablets containing 30% guar gum and 30% xanthan gum behaved as if xanthan gum was the sole rate-retarding gum and drug was released by Fickian diffusion. Release profiles from certain tablets match 12-h literature profiles and the 24-h profile of Inderal® LA. The results confirm that guar gum, xanthan gum, and HPMC can be used for the successful preparation of sustained release oral propranolol hydrochoride tablets.
机译:目的是鉴定使用瓜尔胶,黄原胶和羟丙基甲基纤维素(HPMC)作为增速聚合物,以盐酸普萘洛尔为基质的片剂的特性。通过单独和组合使用这些聚合物的湿法制粒来制备片剂,并且研究了颗粒和片剂的物理性质。在模拟的胃和肠介质中评估药物释放。获得具有适当物理性质的坚固片剂。经验和半经验模型适合于发布数据以阐明发布机制。仅瓜耳胶无法控制药物的释放,直到药物/胶的比例为1:3为止,此时释放模式与Higuchi曲线相吻合。包含HPMC的基质片剂在12小时内提供了接近零级的释放,并且腐蚀是一种促进机制。 HPMC与瓜尔胶或黄原胶的组合产生了Higuchi释放曲线,揭示了HPMC形成的高粘度凝胶的优势。黄原胶作为一种可延迟速率的聚合物,可在24小时内延迟释放,Higuchi模型最适合该数据。当以10%或20%的黄原胶水平与瓜尔胶混合时,黄原胶无法控制释放。但是,含有30%瓜尔胶和30%黄原胶的片剂的表现就好像黄原胶是唯一的缓释胶,药物是通过Fickian扩散释放的。某些片剂的释放特性与12小时文献特性和24小时Inderal®LA特性匹配。结果证实瓜耳胶,黄原胶和HPMC可用于成功制备缓释盐酸普萘洛尔片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号